Inflammation and Hemostasis Biomarkers for Predicting Stroke in Postmenopausal Women: The Women's Health Initiative Observational Study

Journal of Stroke and Cerebrovascular Diseases

Volumn 17, Issue 6, 2008, Pages 344-355

  Kaplan, Robert C ^a   McGinn, Aileen P ^a   Baird, Alison E ^b   Hendrix, Susan L ^c   Kooperberg, Charles ^d   Lynch, John ^b   Rosenbaum, Daniel M ^e   Johnson, Karen C ^f   Strickler, Howard D ^a   Wassertheil Smoller, Sylvia ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e SUNY Downstate Medical Center   (United States)

^f UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

epidemiology; Stroke; women

Indexed keywords

BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 7; C REACTIVE PROTEIN; D DIMER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRINOGEN; HOMOCYSTEINE; INTERLEUKIN 6; NEOPTERIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HEMOSTASIS; HIGH RISK POPULATION; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; POSTMENOPAUSE; PREDICTOR VARIABLE; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; COMORBIDITY; DATA INTERPRETATION, STATISTICAL; FEMALE; HEMOSTATIC DISORDERS; HOMOCYSTEINE; HUMANS; INCIDENCE; INFLAMMATION; INTERLEUKIN-6; LEUKOCYTE COUNT; MIDDLE AGED; NEOPTERIN; POSTMENOPAUSE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; STROKE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 54849433571     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2008.04.006     Document Type: Article

References (25)

1. Jenny N.S., Arnold A.M., Kuller L.H., et al. Serum amyloid P and cardiovascular disease in older men and women: Results from the cardiovascular health study. Arterioscler Thromb Vasc Biol 27 (2007) 352-358
2. Cushman M., Arnold A.M., Psaty B.M., et al. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: The cardiovascular health study. Circulation 112 (2005) 25-31
3. Cao J.J., Thach C., Manolio T.A., et al. C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: The cardiovascular health study. Circulation 108 (2003) 166-170
4. Revilla M., Obach V., Cervera A., et al. A -174G/C polymorphism of the interleukin-6 gene in patients with lacunar infarction. Neurosci Lett 324 (2002) 29-32
5. Cesari M., Penninx B.W., Newman A.B., et al. Inflammatory markers and onset of cardiovascular events: Results from the health ABC study. Circulation 108 (2003) 2317-2322
6. Pradhan A.D., Manson J.E., Rossouw J.E., et al. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: Prospective analysis from the women's health initiative observational study. JAMA 288 (2002) 980-987
7. Jenny N.S., Tracy R.P., Ogg M.S., et al. In the elderly, interleukin-6 plasma levels and the -174G>C polymorphism are associated with the development of cardiovascular disease. Arterioscler Thromb Vasc Biol 22 (2002) 2066-2071
8. Tanne D., Haim M., Boyko V., et al. Soluble intercellular adhesion molecule-1 and risk of future ischemic stroke: A nested case-control study from the Bezafibrate infarction prevention (BIP) study cohort. Stroke 33 (2002) 2182-2186
9. Johansson L., Jansson J.H., Boman K., et al. Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke. Stroke 31 (2000) 26-32
10. Pradhan A.D., LaCroix A.Z., Langer R.D., et al. Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women. Circulation 110 (2004) 292-300
11. Jenny N.S., Arnold A.M., Kuller L.H., et al. Soluble intracellular adhesion molecule-1 is associated with cardiovascular disease risk and mortality in older adults. J Thromb Haemost 4 (2006) 107-113
12. Cesari M., Penninx B.W., Newman A.B., et al. Inflammatory markers and cardiovascular disease (the health, aging and body composition [health ABC] study). Am J Cardiol 92 (2003) 522-528
13. Kistorp C., Raymond I., Pedersen F., et al. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 293 (2005) 1609-1616
14. Danesh J., Wheeler J.G., Hirschfield G.M., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350 (2004) 1387-1397
15. Everett B.M., Kurth T., Buring J.E., et al. The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women. J Am Coll Cardiol 48 (2006) 2235-2242
16. Bos M.J., Schipper C.M., Koudstaal P.J., et al. High serum C-reactive protein level is not an independent predictor for stroke: The Rotterdam study. Circulation 114 (2006) 1591-1598
17. Adams Jr. H.P., Bendixen B.H., Kappelle L.J., et al. Classification of subtype of acute ischemic stroke: Definitions for use in a multicenter clinical trial; TOAST, trial of Org 10172 in acute stroke treatment. Stroke 24 (1993) 35-41
18. Pearson T.A., Mensah G.A., Alexander R.W., et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice; a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
19. Harrell Jr. F.E., Lee K.L., and Mark D.B. Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15 (1996) 361-387
20. Ridker P.M., Buring J.E., Rifai N., et al. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: The Reynolds risk score. JAMA 297 (2007) 611-619
21. Folsom A.R., Rosamond W.D., Shahar E., et al. Prospective study of markers of hemostatic function with risk of ischemic stroke: The atherosclerosis risk in communities (ARIC) study investigators. Circulation 100 (1999) 736-742
22. Margolis K.L., Manson J.E., Greenland P., et al. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: The women's health initiative observational study. Arch Intern Med 165 (2005) 500-508
23. Danesh J., Lewington S., Thompson S.G., et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: An individual participant meta-analysis. JAMA 294 (2005) 1799-1809
24. Tracy R.P., Arnold A.M., Ettinger W., et al. The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: Results from the cardiovascular health study. Arterioscler Thromb Vasc Biol 19 (1999) 1776-1783
25. Kaplan R.C., Ho G.Y., Xue X., et al. Within-individual stability of obesity-related biomarkers among women. Cancer Epidemiol Biomarkers Prev 16 (2007) 1291-1293